Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0002 Transporter Info | ||||
| Gene Name | ABCC2 | ||||
| Transporter Name | Multidrug resistance-associated protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Daunorubicin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 30323 | ||||
| Docking Score | -7.605 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C27H29NO10 | ||||
| Molecular Weight | 527.5 | ||||
| Canonical SMILES |
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O
|
||||
| InChI |
InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1
|
||||
| InChIKey | STQGQHZAVUOBTE-VGBVRHCVSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.8 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 11 | ||
| Xenobiotic Name | Reserpine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5770 | ||||
| Docking Score | -7.457 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C33H40N2O9 | ||||
| Molecular Weight | 608.7 | ||||
| Canonical SMILES |
CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC
|
||||
| InChI |
InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1
|
||||
| InChIKey | QEVHRUUCFGRFIF-MDEJGZGSSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Etodolac Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3308 | ||||
| Docking Score | -7.293 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C17H21NO3 | ||||
| Molecular Weight | 287.35 | ||||
| Canonical SMILES |
CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
|
||||
| InChI |
InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)
|
||||
| InChIKey | NNYBQONXHNTVIJ-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.8 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.